tiprankstipranks
Trending News
More News >
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market

JCR Pharmaceuticals Co., Ltd. (4552) Income Statement

Compare
1 Followers

JCR Pharmaceuticals Co., Ltd. Income Statement

Last quarter (Q3 2025), JCR Pharmaceuticals Co., Ltd.'s total revenue was ¥9.22B, a decrease of -2.36% from the same quarter last year. In Q3, JCR Pharmaceuticals Co., Ltd.'s net income was ¥115.00M. See JCR Pharmaceuticals Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 33.07B¥ 42.87B¥ 34.34B¥ 51.08B¥ 30.09B
Gross Profit
¥ 21.55B¥ 31.25B¥ 25.46B¥ 40.62B¥ 22.27B
Operating Expenses
¥ 28.39B¥ 23.72B¥ 20.48B¥ 20.69B¥ 14.00B
Depreciation and Amortization
¥ 3.37B¥ 3.20B¥ 2.00B¥ 1.95B¥ 1.89B
EBITDA
¥ -2.88B¥ 10.53B¥ 6.97B¥ 21.88B¥ 10.18B
Operating Income
¥ -6.84B¥ 7.53B¥ 4.97B¥ 19.93B¥ 8.27B
Other Income/Expenses
¥ 427.00M¥ -288.00M¥ 437.00M¥ -529.00M¥ 384.00M
Pretax Income
¥ -6.41B¥ 7.24B¥ 5.41B¥ 19.40B¥ 8.65B
Net Income
¥ -4.76B¥ 5.51B¥ 3.77B¥ 14.51B¥ 6.89B
Per Share Metrics
Basic EPS
¥ -38.43¥ 44.13¥ 30.34¥ 117.26¥ 55.80
Diluted EPS
¥ -38.43¥ 43.92¥ 30.22¥ 116.79¥ 55.52
Weighted Average Shares Outstanding
123.83M 124.79M 124.31M 123.72M 123.52M
Weighted Average Shares Outstanding (Diluted)
123.83M 125.40M 124.84M 124.21M 124.13M
Currency in JPY

JCR Pharmaceuticals Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis